• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强的固有免疫反应和对肠道内毒素的不耐受导致人类胆道上皮细胞发生慢性胆管炎。

Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis.

机构信息

Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.

出版信息

Liver Int. 2011 Nov;31(10):1574-88. doi: 10.1111/j.1478-3231.2011.02635.x. Epub 2011 Sep 15.

DOI:10.1111/j.1478-3231.2011.02635.x
PMID:22093333
Abstract

BACKGROUND

Pattern recognition receptors (PRRs) orchestrate the innate immune defence in human biliary epithelial cells (BECs). Tight control of PRR signalling provides tolerance to physiological amounts of intestinal endotoxins in human bile to avoid constant innate immune activation in BECs.

AIMS

We wanted to determine whether inappropriate innate immune responses to intestinal endotoxins contribute to the development and perpetuation of chronic biliary inflammation.

METHODS

We examined PRR-mediated innate immune responses and protective endotoxin tolerance in primary BECs isolated from patients with primary sclerosing cholangitis (PSC), alcoholic liver disease and patients without chronic liver disease. Expression studies comprised northern blots, RT-PCR, Western blots and immunocytochemistry. Functional studies comprised immuno-precipitation Western blots, FACS for endotoxin uptake, and NF-κB activation assays and ELISA for secreted IL-8 and tumour necrosis factor (TNF)-α.

RESULTS

Primary BECs from explanted PSC livers showed reversibly increased TLR and NOD protein expression and activation of the MyD88/IRAK signalling complex. Consecutively, PSC BECs exhibited inappropriate innate immune responses to endotoxins and did not develop immune tolerance after repeated endotoxin exposures. This endotoxin hyper-responsiveness was probably because of the stimulatory effect of abundantly expressed IFN-γ and TNF-α in PSC livers, which stimulated TLR4-mediated endotoxin signalling in BECs, leading to increased TLR4-mediated endotoxin incorporation and impaired inactivation of the TLR4 signalling cascade. As TNF-α inhibition partly restored protective innate immune tolerance, endogenous TNF-α secretion probably contributed to inappropriate endotoxin responses in BECs.

CONCLUSION

Inappropriate innate immune responses to intestinal endotoxins and subsequent endotoxin intolerance because of enhanced PRR signalling in BECs probably contribute to chronic cholangitis.

摘要

背景

模式识别受体(PRRs)在人类胆管上皮细胞(BECs)中协调先天免疫防御。PRR 信号的严格控制为人类胆汁中生理量的肠道内毒素提供了耐受,以避免 BEC 中持续的先天免疫激活。

目的

我们想确定对肠道内毒素的不适当先天免疫反应是否有助于慢性胆管炎症的发展和持续。

方法

我们检查了从原发性硬化性胆管炎(PSC)、酒精性肝病和无慢性肝病患者中分离的原代 BEC 中 PRR 介导的先天免疫反应和保护性内毒素耐受。表达研究包括 Northern blot、RT-PCR、Western blot 和免疫细胞化学。功能研究包括免疫沉淀 Western blot、内毒素摄取的 FACS、NF-κB 激活测定和分泌的 IL-8 和肿瘤坏死因子(TNF)-α 的 ELISA。

结果

来自PSC 肝移植的原代 BEC 显示 TLR 和 NOD 蛋白表达可逆性增加,并且 MyD88/IRAK 信号复合物被激活。连续地,PSC BEC 对内毒素表现出不适当的先天免疫反应,并且在重复内毒素暴露后不会发展免疫耐受。这种内毒素高反应性可能是因为 PSC 肝脏中丰富表达的 IFN-γ 和 TNF-α 的刺激作用,刺激 BEC 中的 TLR4 介导的内毒素信号,导致 TLR4 介导的内毒素掺入增加和 TLR4 信号级联的失活受损。由于 TNF-α 抑制部分恢复了保护性先天免疫耐受,内源性 TNF-α 分泌可能对内毒素在 BEC 中的不适当反应有贡献。

结论

BEC 中 PRR 信号的增强导致对肠道内毒素的不适当先天免疫反应和随后的内毒素不耐受,可能导致慢性胆管炎。

相似文献

1
Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis.增强的固有免疫反应和对肠道内毒素的不耐受导致人类胆道上皮细胞发生慢性胆管炎。
Liver Int. 2011 Nov;31(10):1574-88. doi: 10.1111/j.1478-3231.2011.02635.x. Epub 2011 Sep 15.
2
Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis.胆管上皮细胞抗体在原发性硬化性胆管炎中连接适应性免疫和先天性免疫反应。
Gastroenterology. 2007 Apr;132(4):1504-14. doi: 10.1053/j.gastro.2007.01.039. Epub 2007 Jan 25.
3
TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis: relationship with clinical characteristics.原发性硬化性胆管炎胆管上皮细胞中的TLR4、TLR9和NLRP3:与临床特征的关系
J Gastroenterol Hepatol. 2015 Mar;30(3):600-8. doi: 10.1111/jgh.12711.
4
Endotoxin tolerance in human intrahepatic biliary epithelial cells is induced by upregulation of IRAK-M.人肝内胆管上皮细胞中的内毒素耐受是由IRAK-M的上调所诱导的。
Liver Int. 2006 Oct;26(8):935-42. doi: 10.1111/j.1478-3231.2006.01325.x.
5
Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.TGR5(GPBAR1)在胆管上皮细胞中的下调导致硬化性胆管炎的发病机制。
J Hepatol. 2021 Sep;75(3):634-646. doi: 10.1016/j.jhep.2021.03.029. Epub 2021 Apr 17.
6
Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction.干扰素γ加速由Toll样受体与配体相互作用诱导的胆管上皮细胞的核因子κB激活。
J Clin Pathol. 2006 Feb;59(2):184-90. doi: 10.1136/jcp.2004.023507.
7
The effects of SOCS-1 on liver endotoxin tolerance development induced by a low dose of lipopolysaccharide are related to dampen NF-kappaB-mediated pathway.细胞因子信号转导抑制因子-1(SOCS-1)对低剂量脂多糖诱导的肝脏内毒素耐受形成的影响与抑制核因子-κB(NF-κB)介导的信号通路有关。
Dig Liver Dis. 2008 Jul;40(7):568-77. doi: 10.1016/j.dld.2007.12.019. Epub 2008 Apr 2.
8
Interleukin-32 production associated with biliary innate immunity and proinflammatory cytokines contributes to the pathogenesis of cholangitis in biliary atresia.白细胞介素-32 的产生与胆管先天免疫和促炎细胞因子有关,有助于胆道闭锁性胆管炎的发病机制。
Clin Exp Immunol. 2013 Aug;173(2):268-75. doi: 10.1111/cei.12103.
9
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice.CFTR 的缺失会影响胆管上皮细胞的先天免疫,并导致小鼠 TLR4-NF-κB 介导的炎症反应。
Gastroenterology. 2011 Oct;141(4):1498-508, 1508.e1-5. doi: 10.1053/j.gastro.2011.06.052. Epub 2011 Jun 26.
10
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.用于研究正常和炎症状态下人结肠上皮细胞代谢与免疫功能的体外模型的开发、验证及应用
Dan Med J. 2015 Jan;62(1):B4973.

引用本文的文献

1
CDC42: unlocking a novel therapeutic target for primary sclerosing cholangitis through Mendelian randomization.CDC42:通过孟德尔随机化确定原发性硬化性胆管炎的新型治疗靶点
Am J Transl Res. 2025 Feb 15;17(2):1076-1086. doi: 10.62347/BTYN8678. eCollection 2025.
2
Central role for cholangiocyte pathobiology in cholestatic liver diseases.胆管细胞病理生物学在胆汁淤积性肝病中的核心作用。
Hepatology. 2024 Sep 9. doi: 10.1097/HEP.0000000000001093.
3
Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease.原发性硬化性胆管炎合并炎症性肠病的治疗
Intest Res. 2023 Oct;21(4):420-432. doi: 10.5217/ir.2023.00039. Epub 2023 Sep 1.
4
Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis.原发性硬化性胆管炎 (PSC) 和炎症性肠病 (IBD):一种体现肠道-肝脏轴相互作用的病症。
Exp Mol Med. 2023 Jul;55(7):1380-1387. doi: 10.1038/s12276-023-01042-9. Epub 2023 Jul 18.
5
Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis.结肠炎通过抑制胆汁酸合成改善胆汁淤积性肝病。
Nat Commun. 2023 Jun 6;14(1):3304. doi: 10.1038/s41467-023-38840-8.
6
Cholangiokines: undervalued modulators in the hepatic microenvironment.胆管细胞因子:肝微环境中被低估的调节因子。
Front Immunol. 2023 May 16;14:1192840. doi: 10.3389/fimmu.2023.1192840. eCollection 2023.
7
The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective.肠道微生物群在一些肝脏疾病中的作用:从免疫学角度看。
Front Immunol. 2022 Jul 13;13:923599. doi: 10.3389/fimmu.2022.923599. eCollection 2022.
8
Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review.原发性硬化性胆管炎与炎症性肠病:综述
J Clin Transl Hepatol. 2022 Jun 28;10(3):531-542. doi: 10.14218/JCTH.2021.00344. Epub 2022 Jan 20.
9
TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155.TLR4 信号通路在结肠炎相关癌症发生发展中的作用及其与 microRNA-155 的可能相互作用。
Cell Commun Signal. 2021 Sep 3;19(1):90. doi: 10.1186/s12964-021-00771-6.
10
Primary sclerosing cholangitis.原发性硬化性胆管炎
Transl Gastroenterol Hepatol. 2021 Apr 5;6:29. doi: 10.21037/tgh-20-266. eCollection 2021.